Brookstone Capital Management Has $2.40 Million Stock Holdings in CVS Health Corporation $CVS

Brookstone Capital Management trimmed its stake in shares of CVS Health Corporation (NYSE:CVS) by 63.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,832 shares of the pharmacy operator’s stock after selling 56,464 shares during the period. Brookstone Capital Management’s holdings in CVS Health were worth $2,400,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of CVS. Norges Bank bought a new stake in CVS Health during the 2nd quarter worth about $1,358,698,000. Invesco Ltd. raised its stake in CVS Health by 15.3% in the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock valued at $1,623,270,000 after buying an additional 3,118,626 shares during the period. Robeco Institutional Asset Management B.V. lifted its position in shares of CVS Health by 815.2% in the second quarter. Robeco Institutional Asset Management B.V. now owns 2,663,111 shares of the pharmacy operator’s stock valued at $183,701,000 after buying an additional 2,372,121 shares during the last quarter. Kingstone Capital Partners Texas LLC bought a new position in shares of CVS Health during the 2nd quarter worth approximately $155,185,000. Finally, Jennison Associates LLC increased its holdings in shares of CVS Health by 111.7% during the 2nd quarter. Jennison Associates LLC now owns 4,014,139 shares of the pharmacy operator’s stock worth $276,895,000 after acquiring an additional 2,117,798 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on CVS shares. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of CVS Health in a report on Thursday, December 4th. TD Cowen boosted their target price on shares of CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. Leerink Partners raised their price objective on CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 16th. Evercore ISI increased their price target on shares of CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. Finally, Raymond James Financial lifted their price objective on shares of CVS Health from $75.00 to $90.00 in a research note on Friday, October 31st. Two investment analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $94.67.

CVS Health Trading Up 0.6%

Shares of CVS Health stock opened at $79.60 on Friday. The firm’s 50 day moving average is $78.91 and its 200 day moving average is $72.96. The firm has a market capitalization of $101.04 billion, a PE ratio of 209.47, a price-to-earnings-growth ratio of 0.79 and a beta of 0.48. CVS Health Corporation has a 1 year low of $43.65 and a 1 year high of $85.15. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. The firm had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the business posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.